THURSDAY, Jan. 16, 2025 -- For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with the...
Vous n'êtes pas connecté
THURSDAY, Jan. 23, 2025 -- For patients with resectable esophageal adenocarcinoma, perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) leads to improved survival compared with preoperative chemoradiotherapy...
THURSDAY, Jan. 16, 2025 -- For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with the...
TUESDAY, Jan. 28, 2025 -- For patients with stage IA non-small cell lung cancer (NSCLC), lung resections, including lobectomy and segmentectomy, are...
WEDNESDAY, Jan. 29, 2025 -- Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review...
THURSDAY, Jan. 16, 2025 -- For patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, adjuvant trastuzumab...
The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal of Clinical Oncology...
Updated Date: Thu, 23 Jan 2025 00:00:00 EST
THURSDAY, Jan. 23, 2025 -- For patients diagnosed with cancer, high muscle strength and cardiorespiratory fitness (CRF) are associated with a reduced...
THURSDAY, Jan. 16, 2025 -- For patients with methotrexate (MTX)-acute kidney injury (AKI), glucarpidase is associated with improved renal and...
Around 4 in every 10 cancer patients taking chemotherapy are affected with severe peripheral nerve pain (neuropathy). Neuropathy is a medlinknervous
A recent study finds that sequential gemcitabine/docetaxel treatment offers better outcomes than additional BCG therapy for patients with...